Key Takeaways STERIS Healthcare segment grew 8% in Q1, driven by consumables, equipment and strong service revenues.STERIS AST unit posted 13% revenue growth, backed by service demand, bioprocessing and device volumes.STERIS ended Q1 with $279.7M cash, $1.9B long-term debt and a reduced debt-to-capital ratio of 21.4%.STERIS plc’s (STE) Healthcare segment is gaining from the successful market adoption of its comprehensive offerings, including infection prevention consumables and capital equipment. Service re ...